An APCI LC-MS/MS method for routine dete
β
Damien Montange; Michel BΓ©rard; Martin Demarchi; Patrice Muret; Sarah PiΓ©doux; J
π
Article
π
2010
π
John Wiley and Sons
π
English
β 192 KB
π 1 views
## Abstract The anticancer drug capecitabine and its metabolites [including the active metabolite 5βfluorouracil (5βFU)] display high pharmacokinetic interβpatient variability. Such variability, which may lead to treatment failure or toxicity, could need drug concentration measurement to individual